March 8 (Reuters) – Amarin Corp Plc can promote its fish-oil pill for unapproved uses after the U.S. Food and Drug Administration decided not to appeal a judge’s ruling that the company has the right…
The post UPDATE 1-U.S. FDA to allow Amarin to promote fish oil pill for off-label use appeared first on NASDAQ.